Fundz

Bionyra has successfully launched with a $165 million Series A funding, co-led by Sofinnova Partners and Jeito Capital, to develop solutions for immune-mediated inflammatory diseases.

PRIVATEJun 22, 2026

Amount Raised

$165 Million

Round Type

Series A

FranceBiotechnologyHealth CareTherapeutics

Investors

Vives PartnersSixty Degree CapitalSanofi VenturesArkin BioSofinnova PartnersApollo Health VenturesJeito Capital

Description

Bionyra's oversubscribed Series A raised $165 million, with strong participation from notable investors including Arkin Bio and Sanofi Ventures. The company, co-founded by former Sanofi R&D VP Frédéric Marrache, aims to tackle unmet medical needs in immune-mediated diseases. Their pipeline includes innovative antibody assets currently in phase 1 trials. The funding will accelerate the development of therapies that address pressing patient needs.

Quick answer

Bionyra raised $165 Million in a Series A round, dated June 22, 2026. Investors: Vives Partners, Sixty Degree Capital, Sanofi Ventures, Arkin Bio, Sofinnova Partners, Apollo Health Ventures and Jeito Capital. Bionyra is based in France.

How much did Bionyra raise?
Bionyra raised $165 Million in a Series A round on June 22, 2026.
Who invested in Bionyra?
Vives Partners, Sixty Degree Capital, Sanofi Ventures, Arkin Bio, Sofinnova Partners, Apollo Health Ventures and Jeito Capital are named as investors in this round.
What does Bionyra do?
Bionyra is a biotech company focused on developing innovative therapies for immune-mediated diseases.
Where is Bionyra based and how big is it?
Bionyra is based in France.

Source: Fundz verified event record.

Who to call at Bionyra, and when

A new round usually means Bionyra is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bionyra raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bionyra, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bionyra. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bionyra

Location

France

About

Bionyra is a biotech company focused on developing innovative therapies for immune-mediated diseases. Co-founded by experienced pharma executives, the company aims to address significant unmet medical needs with a differentiated pipeline of antibody assets. Their leading candidates include BYN-002 and BYN-003, which are in phase 1 trials for inflammatory bowel disease. Bionyra leverages half-life extension technology to enhance treatment efficacy and duration.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bionyra raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bionyra's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Bionyra raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.